UiPath, a leading enterprise tech company providing robotic process automation software, has seen its stock plummet since its recent earnings report, making it one of the few tech stocks still trading at 2022 lows. Despite the market’s pessimism, I believe the near-term execution issues are more than priced in, and the stock’s low valuation, coupled with its significant net cash position, presents a strong buy opportunity.
The company’s recent earnings report showed solid revenue growth and a strong dollar-based net retention rate, but its guidance was a major letdown, with management predicting a 9% sequential decline and just 6.3% year-over-year growth in the second quarter. This, coupled with the company’s struggles with contract execution challenges on large deals and a challenging macroeconomic environment, has led to a significant selloff. However, I believe management’s efforts to rectify these issues, along with the company’s strong financial metrics, will eventually lead to a turnaround.
With the stock trading at just around 5x sales, I argue that UiPath does not need a huge acceleration in top-line growth to justify its current price. The company’s profitability, high gross retention rates, and significant net cash balance sheet reduce the risk profile and make the required hurdle rates for stock valuation more achievable. I expect UiPath to eventually bring top-line growth back to the 10% range, at which point the stock could trade at around 7x sales, presenting solid, market-beating upside.
